44 related articles for article (PubMed ID: 15176064)
1. Preparation of tributyrin emulsion and characterization of the binding of the emulsion particles to low-density lipoprotein in vitro.
Su J; Ho PC
J Pharm Sci; 2004 Jul; 93(7):1755-65. PubMed ID: 15176064
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tributyrin lipid emulsion with affinity to low-density lipoprotein: pharmacokinetics in adult male Wistar rats and cellular activity on Caco-2 and HepG2 cell lines.
Su J; He L; Zhang N; Ho PC
J Pharmacol Exp Ther; 2006 Jan; 316(1):62-70. PubMed ID: 16188956
[TBL] [Abstract][Full Text] [Related]
3. Dual function of tributyrin emulsion: solubilization and enhancement of anticancer effect of celecoxib.
Kang SN; Hong SS; Lee MK; Lim SJ
Int J Pharm; 2012 May; 428(1-2):76-81. PubMed ID: 22405988
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma.
Kang SN; Lee E; Lee MK; Lim SJ
Drug Deliv; 2011 Feb; 18(2):143-9. PubMed ID: 20946006
[TBL] [Abstract][Full Text] [Related]
5. Emulsion-based delivery systems for tributyrin, a potential colon cancer preventative agent.
Li Y; Le Maux S; Xiao H; McClements DJ
J Agric Food Chem; 2009 Oct; 57(19):9243-9. PubMed ID: 19731938
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the pharmacokinetics of all-trans-retinoic acid (ATRA) in Wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on caco-2 and HepG2 cell lines.
Su J; Zhang N; Ho PC
J Pharm Sci; 2008 Jul; 97(7):2844-53. PubMed ID: 17879972
[TBL] [Abstract][Full Text] [Related]
7. Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions.
Sakaeda T; Hirano K
J Drug Target; 1998; 6(4):273-84. PubMed ID: 9894695
[TBL] [Abstract][Full Text] [Related]
8. VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting.
Shawer M; Greenspan P; ØIe S; Lu DR
J Pharm Sci; 2002 Jun; 91(6):1405-13. PubMed ID: 12115840
[TBL] [Abstract][Full Text] [Related]
9. Lipid emulsions of palmitoylrhizoxin: effects of particle size on blood dispositions of emulsion lipid and incorporated compound in rats.
Kurihara A; Shibayama Y; Yasuno A; Ikeda M; Hisaoka M
Biopharm Drug Dispos; 1996 May; 17(4):343-53. PubMed ID: 8743405
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation of mixtures of tuna oil, tributyrin and resveratrol in a spray dried powder formulation.
Sanguansri L; Day L; Shen Z; Fagan P; Weerakkody R; Cheng LJ; Rusli J; Augustin MA
Food Funct; 2013 Dec; 4(12):1794-802. PubMed ID: 24121865
[TBL] [Abstract][Full Text] [Related]
11. Structure of triglyceride-rich human low-density lipoproteins according to cryoelectron microscopy.
Sherman MB; Orlova EV; Decker GL; Chiu W; Pownall HJ
Biochemistry; 2003 Dec; 42(50):14988-93. PubMed ID: 14674775
[TBL] [Abstract][Full Text] [Related]
12. Hydrolysis of particulate tributyrin in a fluidized lipase reactor.
Lieberman RB; Ollis DF
Biotechnol Bioeng; 1975 Oct; 17(10):1401-19. PubMed ID: 241438
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
[TBL] [Abstract][Full Text] [Related]
14. High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles.
Vekic J; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Memon L; Zeljkovic A; Bogavac-Stanojevic N; Spasic S
Atherosclerosis; 2009 Mar; 203(1):236-42. PubMed ID: 18603253
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein binds to the 3beta-OH group of cholesterol in LDL particles.
Taskinen S; Hyvönen M; Kovanen PT; Meri S; Pentikäinen MO
Biochem Biophys Res Commun; 2005 Apr; 329(4):1208-16. PubMed ID: 15766555
[TBL] [Abstract][Full Text] [Related]
17. Effect of short-term low- and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects.
Guay V; Lamarche B; Charest A; Tremblay AJ; Couture P
Metabolism; 2012 Jan; 61(1):76-83. PubMed ID: 21816443
[TBL] [Abstract][Full Text] [Related]
18. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.
Nikanjam M; Blakely EA; Bjornstad KA; Shu X; Budinger TF; Forte TM
Int J Pharm; 2007 Jan; 328(1):86-94. PubMed ID: 16959446
[TBL] [Abstract][Full Text] [Related]
19. Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors?
Brinton EA; Nanjee MN; Hopkins PN
J Am Coll Cardiol; 2004 Jun; 43(12):2233-5. PubMed ID: 15193685
[No Abstract] [Full Text] [Related]
20. Coalescence stability of emulsions containing globular milk proteins.
Tcholakova S; Denkov ND; Ivanov IB; Campbell B
Adv Colloid Interface Sci; 2006 Nov; 123-126():259-93. PubMed ID: 16854363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
